Search results
Results from the WOW.Com Content Network
Buspirone, sold under the brand name Buspar among others, is an anxiolytic, a medication primarily used to treat anxiety disorders, particularly generalized anxiety disorder (GAD). [ 10 ] [ 11 ] It is a serotonin 5-HT 1A receptor partial agonist , increasing action at serotonin receptors in the brain. [ 3 ]
Buspar – an anxiolytic used to treat generalized anxiety disorder; Belbuca, Buprenex, Butrans, Subutex, Probuohine (buprenorphine) - an opioid medicine used to treat moderate to severe pain, and in some formulations to treat opioid use disorder; Belsomra – used to treat insomnia
Dextromethorphan/bupropion (DXM/BUP), sold under the brand name Auvelity, is a combination medication for the treatment of major depressive disorder (MDD). [1] Its active components are dextromethorphan (DXM) and bupropion. [1]
The evidence overall supports the effectiveness of bupropion over placebo for the treatment of depression. [41] [18] [42] Some peer-reviewed studies suggest the quality of evidence is low. [42] [18] Some meta-analyses report that bupropion has an at-most small effect size for depression. [43] [44] [42] [45] One meta-analysis reported a large ...
The first oral contraceptive approved for over-the-counter use in the United States will become available in stores and online this month. The medication, known as Opill, has a manufacturer’s ...
Walgreens has agreed to pay $106 million to settle lawsuits that alleged the pharmacy chain submitted false payment claims with government health care programs for prescriptions that were never ...
Buspirone was originally classified as an azaspirodecanedione, shortened to azapirone or azaspirone due to the fact that its chemical structure contained this moiety, and other drugs with similar structures were labeled as such as well. However, despite all being called azapirones, not all of them actually contain the azapirodecanedione ...
The reimbursement pressures can be seen in Walgreens' gross margins over time. Over the past decade, its gross margins have gone from 28.2% in its fiscal year 2014 to 19.5% last fiscal year, which ...